Tenaya Therapeutics, Inc. Common Stock TNYA
i
Market datapartial · fetched 2026-11-13T19:12:43.097Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2027-04-16
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-13T19:12:39.164576676Z
FundamentalsSEC EDGAR · ready · as of 2026-09-30 · fetched 2026-11-13T19:12:40.670714+00:00
Tenaya Therapeutics, Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | ||||||
| 25Δ | ||||||
| 30Δ | ||||||
| 35Δ | 0.96 | 162.6% | 186.5% | |||
| 40Δ | 0.88 | 165.9% | 166.1% | |||
| 45Δ | 0.79 | 169.1% | 145.7% | |||
| 50Δ | 0.71 | 172.3% | 125.3% | |||
| 55Δ | 0.62 | 175.5% | 104.9% | |||
| 60Δ | 0.54 | 178.7% | 84.5% | |||
| 65Δ | ||||||
| 70Δ | ||||||
| 75Δ | ||||||
| 80Δ | ||||||
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
35Δ
- Pseudo strike
- 0.96
- IV
- 162.6%
- B/E move
- 186.5%
- Pseudo strike
- IV
- B/E move
40Δ
- Pseudo strike
- 0.88
- IV
- 165.9%
- B/E move
- 166.1%
- Pseudo strike
- IV
- B/E move
45Δ
- Pseudo strike
- 0.79
- IV
- 169.1%
- B/E move
- 145.7%
- Pseudo strike
- IV
- B/E move
50Δ
- Pseudo strike
- 0.71
- IV
- 172.3%
- B/E move
- 125.3%
- Pseudo strike
- IV
- B/E move
55Δ
- Pseudo strike
- 0.62
- IV
- 175.5%
- B/E move
- 104.9%
- Pseudo strike
- IV
- B/E move
60Δ
- Pseudo strike
- 0.54
- IV
- 178.7%
- B/E move
- 84.5%
- Pseudo strike
- IV
- B/E move
65Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
70Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
75Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
80Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
Options history
No recorded observations
Biotechnology
TRAX
First Tracks Biotherapeutics (Ticker: TRAX) is a forward-thinking biotechnology company focused on developing targeted therapeutics for chronic diseases, utilizing advanced…
More →TRDA
Entrada Therapeutics Inc. (TRDA) is a forward-thinking biotechnology company focused on creating innovative therapies for severe diseases characterized by significant unmet…
More →TRVI
Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on the development and commercialization of Haduvio to treat serious neurology-mediated…
More →TSHA
Taysha Gene Therapies, Inc., a gene therapy company, focuses on the development and commercialization of adeno-associated virus-based gene therapies for the treatment of monogenic…
More →TTRX
Description unavailable
More →TVTX
Description unavailable
More →